Compare ALEMBIC with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs CADILA HEALTHCARE - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC CADILA HEALTHCARE ALEMBIC/
CADILA HEALTHCARE
 
P/E (TTM) x 60.8 24.6 246.6% View Chart
P/BV x 5.2 4.3 121.3% View Chart
Dividend Yield % 0.2 0.8 24.4%  

Financials

 ALEMBIC   CADILA HEALTHCARE
EQUITY SHARE DATA
    ALEMBIC
Mar-18
CADILA HEALTHCARE
Mar-20
ALEMBIC/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs72352 20.4%   
Low Rs34207 16.4%   
Sales per share (Unadj.) Rs4.7139.2 3.4%  
Earnings per share (Unadj.) Rs6.111.8 51.9%  
Cash flow per share (Unadj.) Rs6.218.6 33.6%  
Dividends per share (Unadj.) Rs0.203.50 5.7%  
Dividend yield (eoy) %0.41.3 30.2%  
Book value per share (Unadj.) Rs40.7101.4 40.1%  
Shares outstanding (eoy) m267.031,023.74 26.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.32.0 561.3%   
Avg P/E ratio x8.723.7 36.5%  
P/CF ratio (eoy) x8.515.0 56.3%  
Price / Book Value ratio x1.32.8 47.2%  
Dividend payout %3.329.8 11.0%   
Avg Mkt Cap Rs m14,139286,033 4.9%   
No. of employees `000NA13.4 0.0%   
Total wages/salary Rs m20724,145 0.9%   
Avg. sales/employee Rs ThNM10,632.7-  
Avg. wages/employee Rs ThNM1,801.2-  
Avg. net profit/employee Rs ThNM898.5-  
INCOME DATA
Net Sales Rs m1,255142,531 0.9%  
Other income Rs m3701,139 32.5%   
Total revenues Rs m1,625143,670 1.1%   
Gross profit Rs m11124,198 0.5%  
Depreciation Rs m386,965 0.5%   
Interest Rs m23,418 0.0%   
Profit before tax Rs m44214,954 3.0%   
Minority Interest Rs m0288 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m243,198 0.7%   
Profit after tax Rs m1,63012,044 13.5%  
Gross profit margin %8.917.0 52.1%  
Effective tax rate %5.421.4 25.3%   
Net profit margin %129.88.5 1,536.6%  
BALANCE SHEET DATA
Current assets Rs m1,86787,154 2.1%   
Current liabilities Rs m59182,694 0.7%   
Net working cap to sales %101.63.1 3,248.5%  
Current ratio x3.21.1 299.7%  
Inventory Days Days9471 132.0%  
Debtors Days Days7494 78.4%  
Net fixed assets Rs m1,791133,236 1.3%   
Share capital Rs m5341,024 52.2%   
"Free" reserves Rs m10,324102,733 10.0%   
Net worth Rs m10,858103,757 10.5%   
Long term debt Rs m4132,146 0.1%   
Total assets Rs m11,591236,866 4.9%  
Interest coverage x260.95.4 4,853.6%   
Debt to equity ratio x00.3 1.2%  
Sales to assets ratio x0.10.6 18.0%   
Return on assets %14.16.5 215.6%  
Return on equity %15.011.6 129.3%  
Return on capital %15.213.7 110.6%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1952,752 0.0%   
Fx outflow Rs m26414,504 1.8%   
Net fx Rs m-24438,248 -0.6%   
CASH FLOW
From Operations Rs m23625,054 0.9%  
From Investments Rs m-224-10,123 2.2%  
From Financial Activity Rs m-27-10,942 0.2%  
Net Cashflow Rs m-153,989 -0.4%  

Share Holding

Indian Promoters % 64.0 74.8 85.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 8.3 2.4%  
FIIs % 9.7 5.9 164.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 11.0 237.3%  
Shareholders   54,701 44,069 124.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   AUROBINDO PHARMA  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  ORCHID PHARMA  

Compare ALEMBIC With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher, Coal India and UPL Among Top Gainers(Closing)

Indian share markets continued their positive trend during closing hours today and ended their day on a firm note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Feb 25, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS